Viewing Study NCT06726369

Home Icon Home Search Icon Search Certify Doc Icon Certify Doc Certify Doc Icon Genes Certify Doc Icon Clinical Trials Certify Doc Icon CompTox Processes Icon DrugMatrix Open Targets Icon Open Targets Processes Icon Products Support Icon Support Bugs Icon Bugs
Main Search Make This Study a Gene Therapy Make This Study a Not Gene Therapy Report Bug
Ignite Creation Date: 2025-12-24 @ 11:03 PM
Ignite Modification Date: 2025-12-30 @ 5:49 AM
Study NCT ID: NCT06726369
Status: RECRUITING
Last Update Posted: 2025-03-13
First Post: 2024-12-02
Is NOT Gene Therapy: True
Has Adverse Events: False
Brief Title: A Phase 1 Study to Evaluate the Safety, Pharmacokinetics, and Preliminary Efficacy of MK-6204 (SKB535) for Injection in Participants With Advanced Solid Tumors
Sponsor: Sichuan Kelun-Biotech Biopharmaceutical Co., Ltd.
Organization:
Overview Dates Organization Conditions Design Enrollment Locations Outcomes Modules Raw JSON

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Advanced Solid Tumors View
Keywords:

Keywords

Keyword Brief Keyword Text View
None ADC View
None safety View
None tolerability View
None pharmacokinetics View